LATEST ARTICLES

SEARCH

MENU

Current Edition

acute myeloid leukemia

ASH: Astellas looks for silver linings in failed Xospata combo trial

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol …

15 December 2021 Regional News acute myeloid leukemia Astellas

Continue Reading →

acute myeloid leukemia

Bayer targets 100% green packaging for consumer health brands by 2030 as part of €100 million sustainability plan

Eying growth in oncology, Astellas has suffered an R&D setback for acute myeloid leukemia drug Xospata (gilteritinib). The med flunked a combo trial with Bristol …

15 December 2021 Regional News acute myeloid leukemia Astellas

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Journal For Clinical Studies © 2022, All Rights Reserved – Powered by Teksyte